RxDoctor Payments Data

Christine Pratilas

Pediatric Hematology-Oncology · Baltimore, MDNPI 1336204445

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,053 of the $3,053 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Genentech, Inc..

$3,053in general payments, 2019–2025

Across 3 payments — averaging $1017.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$3K
$960,051in research payments, 2019–2025

Across 239 payments — averaging $4016.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$480K
  • Genentech, Inc.$329K
  • Array Biopharma Inc$81K
  • Epizyme, Inc.$35K
  • Bayer$35K
  • F. Hoffmann-la Roche AG$522

What the payments were for

  • Consulting fees$3,053100%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.3$3,053

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,053 in reported general payments places this provider in the 80th percentile of 52 pediatric hematology-oncology providers in Maryland.

See all pediatric hematology-oncology providers in Maryland

Other pediatric hematology-oncology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →